Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Materials

Growing liver tissue from seed

Hydrogel patterned with cells expands into functioning liver tissue in response to liver damage

by Celia Henry Arnaud
July 24, 2017 | A version of this story appeared in Volume 95, Issue 30

[+]Enlarge
Credit: Sci. Transl. Med.
The liver seeds are made of aggregates (red) of liver cells and connective tissue cells arranged between cords (green) made of blood vessel cells. All the cells are embedded in a degradable hydrogel matrix.
A fluorescence images showing red-labeled aggregates of liver cells and connective tissue cells between green-labeled cords made of blood vessel cells.
Credit: Sci. Transl. Med.
The liver seeds are made of aggregates (red) of liver cells and connective tissue cells arranged between cords (green) made of blood vessel cells. All the cells are embedded in a degradable hydrogel matrix.

The ability to grow new organs from engineered tissue could reduce the need for whole-organ transplantation. But growing new organs with the correct architecture is hard for large, complex organs such as the liver.

Sangeeta N. Bhatia and Kelly R. Stevens of Massachusetts Institute of Technology, Christopher S. Chen of Boston University, and coworkers have engineered patterned “seeds” for planting and growing new liver tissue in the body (Sci. Transl. Med. 2017, DOI: 10.1126/scitranslmed.aah5505).

The researchers constructed the seeds by organizing three types of human cells in a hydrogel matrix. First they made aggregates of liver cells and connective tissue cells. Then they interspersed those aggregates in a hydrogel between cords made of blood-vessel cells.

They implanted the seeds in mice at sites far from the animals’ liver and chemically injured the liver to mimic chronic liver damage. In response, the mouse liver released chemical signals to trigger liver regeneration. These chemicals also caused the tissue seeds to grow by as much as 50-fold over the course of 11 weeks. The expanded tissue produced human drug-metabolizing enzymes and other liver-specific proteins, indicating that it was functioning properly as liver tissue.

Bhatia hopes that such seeds can be designed to grow inside humans. “The idea is to augment a patient’s liver function by implanting this liver seed in the belly—where they sometimes put kidney transplants—and it can grow into a supportive cell mass,” she says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.